10-Q Filing

HealthLynked Corp CIK: 1680139 Q3 2022

Filing Information

Form Type	10-Q
Accession Number	`0001213900-22-072198`
Period End Date	20220930
Filing Date	20221114
Fiscal Year	2022
Fiscal Period	Q3
XBRL Instance	f10q0922_healthlynked_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 88 Income Statement 120 Cash Flow Statement 98 Stockholders Equity 60

Balance Sheet 88 line items

Line Item	Tag	Value	Unit	Period
Cash	`CashEquivalentsAtCarryingValue`	$158.16K	USD	Point-in-time
Cash	`CashEquivalentsAtCarryingValue`	$3.29M	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $-0- and $13,972 as of September 30, 2022 and December 31, 2021, respectively	`AccountsReceivableNetCurrent`	$63.85K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $-0- and $13,972 as of September 30, 2022 and December 31, 2021, respectively	`AccountsReceivableNetCurrent`	$86.29K	USD	Point-in-time
Inventory	`InventoryNet`	$134.93K	USD	Point-in-time
Inventory	`InventoryNet`	$188.55K	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$137.63K	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$94.97K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts (in Dollars)	`AllowanceForDoubtfulAccountsReceivableCurrent`	-	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts (in Dollars)	`AllowanceForDoubtfulAccountsReceivableCurrent`	$13.97K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$3.65M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$505.53K	USD	Point-in-time
Property, plant and equipment, net of accumulated depreciation (in Dollars)	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$283.51K	USD	Point-in-time
Property, plant and equipment, net of accumulated depreciation of $368,985 and $283,512 as of September 30, 2022 and December 31, 2021, respectively	`PropertyPlantAndEquipmentNet`	$441.33K	USD	Point-in-time
Property, plant and equipment, net of accumulated depreciation of $368,985 and $283,512 as of September 30, 2022 and December 31, 2021, respectively	`PropertyPlantAndEquipmentNet`	$350.48K	USD	Point-in-time
Property, plant and equipment, net of accumulated depreciation (in Dollars)	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$368.99K	USD	Point-in-time
Intangible assets, net of accumulated amortization of $1,410,250 and $873,417 as of September 30, 2022 and December 31, 2021, respectively	`FiniteLivedIntangibleAssetsNet`	$4.34M	USD	Point-in-time
Intangible assets, net of accumulated amortization (in Dollars)	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$873.42K	USD	Point-in-time
Intangible assets, net of accumulated amortization of $1,410,250 and $873,417 as of September 30, 2022 and December 31, 2021, respectively	`FiniteLivedIntangibleAssetsNet`	$4.88M	USD	Point-in-time
Intangible assets, net of accumulated amortization (in Dollars)	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$1.41M	USD	Point-in-time
Notes payable, current portion, net of unamortized original issue discount (in Dollars)	`DebtInstrumentUnamortizedDiscountCurrent`	-	USD	Point-in-time
Goodwill	`Goodwill`	$1.15M	USD	Point-in-time
Goodwill	`Goodwill`	$1.47M	USD	Point-in-time
Notes payable, current portion, net of unamortized original issue discount (in Dollars)	`DebtInstrumentUnamortizedDiscountCurrent`	$20.88K	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Right of use lease assets	`OperatingLeaseRightOfUseAsset`	$636.27K	USD	Point-in-time
Right of use lease assets	`OperatingLeaseRightOfUseAsset`	$526.73K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Deferred equity compensation and deposits	`DeferredEquityCompensationAndDeposit`	$84.09K	USD	Point-in-time
Deferred equity compensation and deposits	`DeferredEquityCompensationAndDeposit`	$138.62K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	237.89M	shares	Point-in-time
Total Assets	`Assets`	$7.48M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	247.86M	shares	Point-in-time
Total Assets	`Assets`	$10.69M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	237.89M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	247.86M	shares	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$1.19M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$790.84K	USD	Point-in-time
Contract liabilities	`ContractWithCustomerLiabilityCurrent`	$65.25K	USD	Point-in-time
Contract liabilities	`ContractWithCustomerLiabilityCurrent`	$72.84K	USD	Point-in-time
Lease liability, current portion	`OperatingLeaseLiabilityCurrent`	$378.76K	USD	Point-in-time
Lease liability, current portion	`OperatingLeaseLiabilityCurrent`	$288.97K	USD	Point-in-time
Due to related party, current portion	`DueToOtherRelatedPartiesClassifiedCurrent`	$300.60K	USD	Point-in-time
Due to related party, current portion	`DueToOtherRelatedPartiesClassifiedCurrent`	$300.60K	USD	Point-in-time
Common stock issuable, par value (in Dollars per share)	`CommonStockParValue`	$0.00	USD	Point-in-time
Common stock issuable, par value (in Dollars per share)	`CommonStockParValue`	$0.00	USD	Point-in-time
Notes payable, current portion, net of unamortized original issue discount of $20,879 and $-0- as of September 30, 2022 and December 31, 2021	`NotesPayableCurrent`	-	USD	Point-in-time
Notes payable, current portion, net of unamortized original issue discount of $20,879 and $-0- as of September 30, 2022 and December 31, 2021	`NotesPayableCurrent`	$397.87K	USD	Point-in-time
Common stock issuable, shares	`CommonStockIssuableShares`	1.33M	shares	Point-in-time
Liability-classified equity instruments, current portion	`LiabilityclassifiedEquityInstrumentsCurrentPortion`	$61.25K	USD	Point-in-time
Common stock issuable, shares	`CommonStockIssuableShares`	719,366.00	shares	Point-in-time
Liability-classified equity instruments, current portion	`LiabilityclassifiedEquityInstrumentsCurrentPortion`	$30.62K	USD	Point-in-time
Contingent acquisition consideration, current portion	`BusinessCombinationContingentConsiderationLiabilityCurrent`	$403.47K	USD	Point-in-time
Contingent acquisition consideration, current portion	`BusinessCombinationContingentConsiderationLiabilityCurrent`	$128.07K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$1.92M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$2.50M	USD	Point-in-time
Government notes payable, long term portion	`GovernmentAndVendorNotesPayableLongTermPortion`	$450.00K	USD	Point-in-time
Government notes payable, long term portion	`GovernmentAndVendorNotesPayableLongTermPortion`	$450.00K	USD	Point-in-time
Liability-classified equity instruments, long term portion	`LongTermDebtNoncurrent`	$101.25K	USD	Point-in-time
Liability-classified equity instruments, long term portion	`LongTermDebtNoncurrent`	$52.50K	USD	Point-in-time
Contingent acquisition consideration, long term portion	`CapitalLeaseObligationsNoncurrent`	$184.66K	USD	Point-in-time
Contingent acquisition consideration, long term portion	`CapitalLeaseObligationsNoncurrent`	$782.22K	USD	Point-in-time
Lease liability, long term portion	`OperatingLeaseLiabilityNoncurrent`	$239.22K	USD	Point-in-time
Lease liability, long term portion	`OperatingLeaseLiabilityNoncurrent`	$259.85K	USD	Point-in-time
Total Liabilities	`Liabilities`	$3.44M	USD	Point-in-time
Total Liabilities	`Liabilities`	$3.49M	USD	Point-in-time
Common stock, par value $0.0001 per share, 500,000,000 shares authorized, 247,857,625 and 237,893,473 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively	`CommonStockValue`	$23.79K	USD	Point-in-time
Common stock, par value $0.0001 per share, 500,000,000 shares authorized, 247,857,625 and 237,893,473 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively	`CommonStockValue`	$24.79K	USD	Point-in-time
Series B convertible preferred stock, par value $0.001 per share, 20,000,000 shares authorized, 2,750,000 and 2,750,000 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively	`PreferredStockValue`	$2.75K	USD	Point-in-time
Series B convertible preferred stock, par value $0.001 per share, 20,000,000 shares authorized, 2,750,000 and 2,750,000 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively	`PreferredStockValue`	$2.75K	USD	Point-in-time
Common stock issuable, $0.0001 par value; 1,329,469 and 719,366 shares as of September 30, 2022 and December 31, 2021, respectively	`CommonStockIssuableValue`	$282.35K	USD	Point-in-time
Common stock issuable, $0.0001 par value; 1,329,469 and 719,366 shares as of September 30, 2022 and December 31, 2021, respectively	`CommonStockIssuableValue`	$345.35K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$39.10M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$40.41M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-32.21M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-36.75M	USD	Point-in-time
Total Shareholders Equity	`StockholdersEquity`	$6.14M	USD	Point-in-time
Total Shareholders Equity	`StockholdersEquity`	$4.80M	USD	Point-in-time
Total Shareholders Equity	`StockholdersEquity`	$4.04M	USD	Point-in-time
Total Shareholders Equity	`StockholdersEquity`	$8.77M	USD	Point-in-time
Total Shareholders Equity	`StockholdersEquity`	$6.17M	USD	Point-in-time
Total Shareholders Equity	`StockholdersEquity`	$6.30M	USD	Point-in-time
Total Shareholders Equity	`StockholdersEquity`	$1.35M	USD	Point-in-time
Total Shareholders Equity	`StockholdersEquity`	$7.20M	USD	Point-in-time
Total Liabilities and Shareholders Equity	`LiabilitiesAndStockholdersEquity`	$10.69M	USD	Point-in-time
Total Liabilities and Shareholders Equity	`LiabilitiesAndStockholdersEquity`	$7.48M	USD	Point-in-time

Income Statement 120 line items

Line Item	Tag	Value	Unit	Period
Patient service revenue, net	`RevenueFromContractWithCustomerIncludingAssessedTax`	$4.07M	USD	3 Qtrs
Patient service revenue, net	`RevenueFromContractWithCustomerIncludingAssessedTax`	$1.39M	USD	1 Quarter
Patient service revenue, net	`RevenueFromContractWithCustomerIncludingAssessedTax`	$1.26M	USD	1 Quarter
Patient service revenue, net	`RevenueFromContractWithCustomerIncludingAssessedTax`	$4.38M	USD	3 Qtrs
Medicare shared savings revenue	`RevenueNotFromContractWithCustomerOther`	-	USD	3 Qtrs
Medicare shared savings revenue	`RevenueNotFromContractWithCustomerOther`	$2.42M	USD	1 Quarter
Medicare shared savings revenue	`RevenueNotFromContractWithCustomerOther`	$2.42M	USD	3 Qtrs
Medicare shared savings revenue	`RevenueNotFromContractWithCustomerOther`	-	USD	1 Quarter
Subscription, consulting and event revenue	`SubscriptionConsultingAndEventRevenue`	$-69.59K	USD	1 Quarter
Subscription, consulting and event revenue	`SubscriptionConsultingAndEventRevenue`	$-229.11K	USD	3 Qtrs
Subscription, consulting and event revenue	`SubscriptionConsultingAndEventRevenue`	$-260.49K	USD	3 Qtrs
Subscription, consulting and event revenue	`SubscriptionConsultingAndEventRevenue`	$-89.98K	USD	1 Quarter
Product revenue	`ProductRevenue`	$372.88K	USD	3 Qtrs
Product revenue	`ProductRevenue`	$512.33K	USD	3 Qtrs
Product revenue	`ProductRevenue`	$95.45K	USD	1 Quarter
Product revenue	`ProductRevenue`	$161.46K	USD	1 Quarter
Total revenue	`Revenues`	$4.70M	USD	3 Qtrs
Total revenue	`Revenues`	$4.04M	USD	1 Quarter
Total revenue	`Revenues`	$1.45M	USD	1 Quarter
Total revenue	`Revenues`	$7.54M	USD	3 Qtrs
Practice salaries and benefits	`LaborAndRelatedExpense`	$739.02K	USD	1 Quarter
Practice salaries and benefits	`LaborAndRelatedExpense`	$2.34M	USD	3 Qtrs
Practice salaries and benefits	`LaborAndRelatedExpense`	$810.06K	USD	1 Quarter
Practice salaries and benefits	`LaborAndRelatedExpense`	$2.31M	USD	3 Qtrs
Other practice operating expenses	`OtherCostAndExpenseOperating`	$695.30K	USD	1 Quarter
Other practice operating expenses	`OtherCostAndExpenseOperating`	$549.09K	USD	1 Quarter
Other practice operating expenses	`OtherCostAndExpenseOperating`	$1.79M	USD	3 Qtrs
Other practice operating expenses	`OtherCostAndExpenseOperating`	$1.90M	USD	3 Qtrs
Medicare shared savings expenses	`MedicareSharedSavingsExpenses`	$1.75M	USD	1 Quarter
Medicare shared savings expenses	`MedicareSharedSavingsExpenses`	$2.16M	USD	3 Qtrs
Medicare shared savings expenses	`MedicareSharedSavingsExpenses`	$802.41K	USD	3 Qtrs
Medicare shared savings expenses	`MedicareSharedSavingsExpenses`	$337.53K	USD	1 Quarter
Cost of product revenue	`CostOfProductRevenue`	$145.43K	USD	1 Quarter
Cost of product revenue	`CostOfProductRevenue`	$87.78K	USD	1 Quarter
Cost of product revenue	`CostOfProductRevenue`	$419.13K	USD	3 Qtrs
Cost of product revenue	`CostOfProductRevenue`	$474.03K	USD	3 Qtrs
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$3.66M	USD	3 Qtrs
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$3.68M	USD	3 Qtrs
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$1.09M	USD	1 Quarter
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$1.15M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$209.50K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$205.31K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$623.44K	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$622.31K	USD	3 Qtrs
Total Operating Expenses and Costs	`OperatingExpenses`	$3.23M	USD	1 Quarter
Total Operating Expenses and Costs	`OperatingExpenses`	$9.76M	USD	3 Qtrs
Total Operating Expenses and Costs	`OperatingExpenses`	$11.01M	USD	3 Qtrs
Total Operating Expenses and Costs	`OperatingExpenses`	$4.54M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-3.47M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-5.06M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-490.31K	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-1.78M	USD	1 Quarter
Gain (loss) on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Gain (loss) on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-4.96M	USD	3 Qtrs
Gain (loss) on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	3 Qtrs
Gain (loss) on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Change in fair value of debt	`GainsLossesOnRestructuringOfDebt`	-	USD	1 Quarter
Change in fair value of debt	`GainsLossesOnRestructuringOfDebt`	-	USD	1 Quarter
Change in fair value of debt	`GainsLossesOnRestructuringOfDebt`	$-19.25K	USD	3 Qtrs
Change in fair value of debt	`GainsLossesOnRestructuringOfDebt`	-	USD	3 Qtrs
Financing cost	`FinancingInterestExpense`	$110.00K	USD	1 Quarter
Financing cost	`FinancingInterestExpense`	-	USD	3 Qtrs
Financing cost	`FinancingInterestExpense`	-	USD	1 Quarter
Financing cost	`FinancingInterestExpense`	$110.00K	USD	3 Qtrs
Amortization of original issue discounts on notes payable	`AmortizationOfOriginalIssueDiscountsOnNotesPayable`	$-21.02K	USD	3 Qtrs
Amortization of original issue discounts on notes payable	`AmortizationOfOriginalIssueDiscountsOnNotesPayable`	-	USD	1 Quarter
Amortization of original issue discounts on notes payable	`AmortizationOfOriginalIssueDiscountsOnNotesPayable`	$-21.02K	USD	1 Quarter
Amortization of original issue discounts on notes payable	`AmortizationOfOriginalIssueDiscountsOnNotesPayable`	-	USD	3 Qtrs
Change in fair value of contingent acquisition consideration	`GainLossOnChangeInFairValueOfContingentAcquisitionConsideration`	$126.41K	USD	1 Quarter
Change in fair value of contingent acquisition consideration	`GainLossOnChangeInFairValueOfContingentAcquisitionConsideration`	$665.57K	USD	3 Qtrs
Change in fair value of contingent acquisition consideration	`GainLossOnChangeInFairValueOfContingentAcquisitionConsideration`	$-234.68K	USD	3 Qtrs
Change in fair value of contingent acquisition consideration	`GainLossOnChangeInFairValueOfContingentAcquisitionConsideration`	$133.48K	USD	1 Quarter
Interest (expense) income	`NonoperatingIncomeExpense`	$-15.15K	USD	3 Qtrs
Interest (expense) income	`NonoperatingIncomeExpense`	$-5.64K	USD	1 Quarter
Interest (expense) income	`NonoperatingIncomeExpense`	$-4.12K	USD	1 Quarter
Interest (expense) income	`NonoperatingIncomeExpense`	$-13.08K	USD	3 Qtrs
Total other income (expenses)	`OtherOperatingIncomeExpenseNet`	$-5.22M	USD	3 Qtrs
Total other income (expenses)	`OtherOperatingIncomeExpenseNet`	$-3.18K	USD	1 Quarter
Total other income (expenses)	`OtherOperatingIncomeExpenseNet`	$122.29K	USD	1 Quarter
Total other income (expenses)	`OtherOperatingIncomeExpenseNet`	$519.40K	USD	3 Qtrs
Net loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-368.02K	USD	1 Quarter
Net loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-8.70M	USD	3 Qtrs
Net loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-1.78M	USD	1 Quarter
Net loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-4.54M	USD	3 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	3 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	3 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.70M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-368.02K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-4.54M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-1.78M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-7.82M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.59M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-505.76K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.17M	USD	1 Quarter
Deemed dividend - amortization of beneficial conversion feature	`DeemedDividendAmortizationOfBeneficialConversionFeature`	$88.39K	USD	1 Quarter
Deemed dividend - amortization of beneficial conversion feature	`DeemedDividendAmortizationOfBeneficialConversionFeature`	$265.18K	USD	3 Qtrs
Deemed dividend - amortization of beneficial conversion feature	`DeemedDividendAmortizationOfBeneficialConversionFeature`	$265.18K	USD	3 Qtrs
Deemed dividend - amortization of beneficial conversion feature	`DeemedDividendAmortizationOfBeneficialConversionFeature`	$88.39K	USD	1 Quarter
Net loss to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-1.87M	USD	1 Quarter
Net loss to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-456.41K	USD	1 Quarter
Net loss to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-4.81M	USD	3 Qtrs
Net loss to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-8.96M	USD	3 Qtrs
Basic (in Dollars per share)	`EarningsPerShareBasic`	$-0.04	USD	3 Qtrs
Basic (in Dollars per share)	`EarningsPerShareBasic`	$-0.01	USD	1 Quarter
Basic (in Dollars per share)	`EarningsPerShareBasic`	-	USD	1 Quarter
Basic (in Dollars per share)	`EarningsPerShareBasic`	$-0.02	USD	3 Qtrs
Fully diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-0.02	USD	3 Qtrs
Fully diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-0.04	USD	3 Qtrs
Fully diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-0.01	USD	1 Quarter
Fully diluted (in Dollars per share)	`EarningsPerShareDiluted`	-	USD	1 Quarter
Basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	224.66M	shares	3 Qtrs
Basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	232.20M	shares	1 Quarter
Basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	243.36M	shares	1 Quarter
Basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	240.01M	shares	3 Qtrs
Fully diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	232.20M	shares	1 Quarter
Fully diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	224.66M	shares	3 Qtrs
Fully diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	240.01M	shares	3 Qtrs
Fully diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	243.36M	shares	1 Quarter

Cash Flow Statement 98 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-8.70M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-368.02K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-4.54M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-1.78M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-7.82M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.59M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-505.76K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.17M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$622.31K	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$623.44K	USD	3 Qtrs
Stock based compensation, including amortization of deferred equity compensation	`EmployeeBenefitsAndShareBasedCompensation`	$326.49K	USD	3 Qtrs
Stock based compensation, including amortization of deferred equity compensation	`EmployeeBenefitsAndShareBasedCompensation`	$575.00K	USD	3 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	-	USD	3 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$21.02K	USD	3 Qtrs
Stock-based financing cost	`ShareBasedCompensation`	$100.00K	USD	3 Qtrs
Stock-based financing cost	`ShareBasedCompensation`	-	USD	3 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-4.96M	USD	3 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	3 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Change in fair value of debt	`GainsLossesOnRestructuringOfDebt`	-	USD	1 Quarter
Change in fair value of debt	`GainsLossesOnRestructuringOfDebt`	-	USD	1 Quarter
Change in fair value of debt	`GainsLossesOnRestructuringOfDebt`	$-19.25K	USD	3 Qtrs
Change in fair value of debt	`GainsLossesOnRestructuringOfDebt`	-	USD	3 Qtrs
Change in fair value of contingent acquisition consideration	`GainLossesOnChangeInFairValueOfContingentAcquisitionConsideration`	$-234.68K	USD	3 Qtrs
Change in fair value of contingent acquisition consideration	`GainLossesOnChangeInFairValueOfContingentAcquisitionConsideration`	$665.57K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$25.83K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-22.43K	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$40.34K	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$11.71K	USD	3 Qtrs
Prepaid expenses and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$40.52K	USD	3 Qtrs
Prepaid expenses and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-29.07K	USD	3 Qtrs
Right of use lease assets	`IncreaseDecreaseInRightOfUseLeaseAssets`	$78.83K	USD	3 Qtrs
Right of use lease assets	`IncreaseDecreaseInRightOfUseLeaseAssets`	$255.63K	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$370.41K	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$800.73K	USD	3 Qtrs
Lease liability	`IncreaseDecreaseInLeaseLiability`	$82.10K	USD	3 Qtrs
Lease liability	`IncreaseDecreaseInLeaseLiability`	$254.76K	USD	3 Qtrs
Contract liabilities	`IncreaseDecreaseInDeferredRevenue`	$-58.89K	USD	3 Qtrs
Contract liabilities	`IncreaseDecreaseInDeferredRevenue`	$-7.58K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.63M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.76M	USD	3 Qtrs
Acquisition, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	3 Qtrs
Acquisition, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$313.80K	USD	3 Qtrs
Payment of contingent acquisition consideration	`PaymentForContingentConsiderationLiabilityInvestingActivities`	$207.38K	USD	3 Qtrs
Payment of contingent acquisition consideration	`PaymentForContingentConsiderationLiabilityInvestingActivities`	$322.11K	USD	3 Qtrs
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$23.56K	USD	3 Qtrs
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$12.47K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-334.58K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-544.75K	USD	3 Qtrs
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$706.79K	USD	3 Qtrs
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$6.95M	USD	3 Qtrs
Proceeds from exercise of options and warrants	`ProceedsFromExerciseOfOptionsAndWarrants`	-	USD	3 Qtrs
Proceeds from exercise of options and warrants	`ProceedsFromExerciseOfOptionsAndWarrants`	$350.20K	USD	3 Qtrs
Proceeds from notes payable	`ProceedsFromNotesPayable`	-	USD	3 Qtrs
Proceeds from notes payable	`ProceedsFromNotesPayable`	$522.50K	USD	3 Qtrs
Repayment of notes payable	`RepaymentsOfNotesPayable`	$55.38K	USD	3 Qtrs
Repayment of notes payable	`RepaymentsOfNotesPayable`	$51.11K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.17M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$7.25M	USD	3 Qtrs
Net (decrease) increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$5.29M	USD	3 Qtrs
Net (decrease) increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-3.13M	USD	3 Qtrs
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$162.18K	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.29M	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.45M	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$158.16K	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$162.18K	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.29M	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.45M	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$158.16K	USD	Point-in-time
Cash paid during the period for interest	`InterestPaidNet`	$2.51K	USD	3 Qtrs
Cash paid during the period for interest	`InterestPaidNet`	$232.00	USD	3 Qtrs
Cash paid during the period for income tax	`IncomeTaxesPaid`	-	USD	3 Qtrs
Cash paid during the period for income tax	`IncomeTaxesPaid`	-	USD	3 Qtrs
Fair value of shares issued as purchase price consideration	`FairValueOfSharesIssuedAsPurchasePriceConsideration`	-	USD	3 Qtrs
Fair value of shares issued as purchase price consideration	`FairValueOfSharesIssuedAsPurchasePriceConsideration`	$103.80K	USD	3 Qtrs
Common stock issuable issued during period	`CommonStockToBeIssuedNowIssued`	$192.55K	USD	3 Qtrs
Common stock issuable issued during period	`CommonStockToBeIssuedNowIssued`	$112.53K	USD	3 Qtrs
Net carrying value of equity liabilities (assets) written off	`NetCarryingValueOfEquityLiabilitiesassetsWrittenOff`	$21.36K	USD	3 Qtrs
Net carrying value of equity liabilities (assets) written off	`NetCarryingValueOfEquityLiabilitiesassetsWrittenOff`	-	USD	3 Qtrs
Proceeds from sale of common stock under Standby Equity Purchase Agreement applied to note payable balance	`ProceedsFromSaleOfCommonStockUnderStandbyEquityPurchaseAgreementAppliedToNote`	$125.62K	USD	3 Qtrs
Debt discount and original issue discount allocated to proceeds of notes payable	`DebtDiscountAndOriginalIssueDiscountAllocatedToProceedsOfNotesPayable`	$38.50K	USD	3 Qtrs
Recognition of operating lease: right of use asset and lease liability	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	-	USD	3 Qtrs
Recognition of operating lease: right of use asset and lease liability	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$284.90K	USD	3 Qtrs
Forgiveness of government loans	`GainLossOnSalesOfLoansNet`	-	USD	3 Qtrs
Forgiveness of government loans	`GainLossOnSalesOfLoansNet`	$632.83K	USD	3 Qtrs
Fair value of warrants issued for professional service	`FairValueAdjustmentOfWarrants`	-	USD	3 Qtrs
Fair value of warrants issued for professional service	`FairValueAdjustmentOfWarrants`	$36.03K	USD	3 Qtrs
Incremental fair value of warrants modified to extend maturity date of convertible notes payable	`IncrementalFairValueOfWarrantsModifiedToExtendMaturityDateOfConvertibleNotesPayable`	-	USD	Point-in-time
Incremental fair value of warrants modified to extend maturity date of convertible notes payable	`IncrementalFairValueOfWarrantsModifiedToExtendMaturityDateOfConvertibleNotesPayable`	$126.50K	USD	Point-in-time
Conversion of convertible note payable to common shares	`ConversionOfConvertibleNotesPayableToCommonStock`	$4.06M	USD	3 Qtrs
Conversion of convertible note payable to common shares	`ConversionOfConvertibleNotesPayableToCommonStock`	-	USD	3 Qtrs
Fair value of warrants issued in connection with conversion of convertible notes payable	`FairValueOfWarrantsIssuedInConnectionWithConversionOfConvertibleNotesPayable`	$3.07M	USD	Point-in-time
Fair value of warrants issued in connection with conversion of convertible notes payable	`FairValueOfWarrantsIssuedInConnectionWithConversionOfConvertibleNotesPayable`	-	USD	Point-in-time
Accrued liabilities relieved upon cashless exercise of warrants	`AccruedLiabilitiesRelievedUponCashlessExerciseOfWarrants`	-	USD	3 Qtrs
Accrued liabilities relieved upon cashless exercise of warrants	`AccruedLiabilitiesRelievedUponCashlessExerciseOfWarrants`	$614.22K	USD	3 Qtrs
Contingent acquisition consideration payable in common stock	`ContingentAcquisitionConsiderationPayableInCommonStock`	$366.30K	USD	3 Qtrs
Contingent acquisition consideration payable in common stock	`ContingentAcquisitionConsiderationPayableInCommonStock`	-	USD	3 Qtrs

Stockholders Equity 60 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$6.14M	USD	Point-in-time
Balance	`StockholdersEquity`	$4.80M	USD	Point-in-time
Balance	`StockholdersEquity`	$4.04M	USD	Point-in-time
Balance	`StockholdersEquity`	$8.77M	USD	Point-in-time
Balance	`StockholdersEquity`	$6.17M	USD	Point-in-time
Balance	`StockholdersEquity`	$6.30M	USD	Point-in-time
Balance	`StockholdersEquity`	$1.35M	USD	Point-in-time
Balance	`StockholdersEquity`	$7.20M	USD	Point-in-time
Sales of common stock	`SaleOfCommonAndPreferredStockInExchangeForMarketableSecurities`	$1.61M	USD	1 Quarter
Sales of common stock	`SaleOfCommonAndPreferredStockInExchangeForMarketableSecurities`	$2.98M	USD	1 Quarter
Sales of common stock	`SaleOfCommonAndPreferredStockInExchangeForMarketableSecurities`	$177.68K	USD	1 Quarter
Sales of common stock	`SaleOfCommonAndPreferredStockInExchangeForMarketableSecurities`	$8.28K	USD	1 Quarter
Sales of shares pursuant to Standby Equity Purchase Agreement	`StockIssuedDuringPeriodValuePurchaseOfAssets`	$297.40K	USD	1 Quarter
Stock based financing fees	`StockIssuedDuringPeriodValueConversionOfUnits`	$100.00K	USD	1 Quarter
Other sales of common stock	`StockIssuedDuringPeriodValueOther`	$406.08K	USD	1 Quarter
Fair value of warrants allocated to proceeds of common stock	`StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants`	$690.58K	USD	1 Quarter
Fair value of warrants allocated to proceeds of common stock	`StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants`	$1.41M	USD	1 Quarter
Fair value of warrants allocated to proceeds of common stock	`StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants`	$118.92K	USD	1 Quarter
Fair value of warrants allocated to proceeds of common stock	`StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants`	$1.72K	USD	1 Quarter
Fair value of warrants allocated to proceeds of common stock	`StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants`	$82.32K	USD	1 Quarter
Conversion of convertible notes payable to common stock	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$4.06M	USD	1 Quarter
Fair value of warrants issued in connection with conversion and retirement of convertible notes payable	`FairValueOfWarrantsIssuedAndModifiedInConnectionWithConversionAndRetirementOfConve`	$3.20M	USD	1 Quarter
Fair value of warrants issued for professional services	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$32.43K	USD	1 Quarter
Fair value of warrants issued for professional services	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$3.60K	USD	1 Quarter
Fair value of warrants issued for professional services	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$3.60K	USD	1 Quarter
Contingent acquisition consideration issuable	`StockIssuedDuringPeriodValueIssuedForServices`	$366.30K	USD	1 Quarter
Shares issued in acquisition of AEU	`StockIssuedDuringPeriodValueAcquisitions`	$103.80K	USD	1 Quarter
Consultant and director fees payable with common shares and warrants	`ConsultantFeesPayableWithCommonSharesAndWarrants`	$105.43K	USD	1 Quarter
Consultant and director fees payable with common shares and warrants	`ConsultantFeesPayableWithCommonSharesAndWarrants`	$86.81K	USD	1 Quarter
Consultant and director fees payable with common shares and warrants	`ConsultantFeesPayableWithCommonSharesAndWarrants`	$81.52K	USD	1 Quarter
Consultant and director fees payable with common shares and warrants	`ConsultantFeesPayableWithCommonSharesAndWarrants`	$89.73K	USD	1 Quarter
Consultant and director fees payable with common shares and warrants	`ConsultantFeesPayableWithCommonSharesAndWarrants`	$237.33K	USD	1 Quarter
Consultant and director fees payable with common shares and warrants	`ConsultantFeesPayableWithCommonSharesAndWarrants`	$92.85K	USD	1 Quarter
Shares and options issued pursuant to employee equity incentive plan	`StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan`	$37.41K	USD	1 Quarter
Shares and options issued pursuant to employee equity incentive plan	`StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan`	$63.66K	USD	1 Quarter
Shares and options issued pursuant to employee equity incentive plan	`StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan`	$20.44K	USD	1 Quarter
Exercise of stock warrants	`Exerciseofwarrants`	$676.72K	USD	1 Quarter
Exercise of stock warrants	`Exerciseofwarrants`	$215.00K	USD	1 Quarter
Exercise of stock warrants	`Exerciseofwarrants`	$56.25K	USD	1 Quarter
Shares and options issued to employees	`StockIssuedDuringPeriodValueEmployeeBenefitPlan`	$36.00	USD	1 Quarter
Shares and options issued to employees	`StockIssuedDuringPeriodValueEmployeeBenefitPlan`	$26.78K	USD	1 Quarter
Shares and options issued to employees	`StockIssuedDuringPeriodValueEmployeeBenefitPlan`	$31.12K	USD	1 Quarter
Exercise of stock options	`ExerciseOfStockOptionsValue`	$13.30K	USD	1 Quarter
Exercise of stock options	`ExerciseOfStockOptionsValue`	$3.15K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.70M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-368.02K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-4.54M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-1.78M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-7.82M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.59M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-505.76K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.17M	USD	1 Quarter
Balance	`StockholdersEquity`	$6.14M	USD	Point-in-time
Balance	`StockholdersEquity`	$4.80M	USD	Point-in-time
Balance	`StockholdersEquity`	$4.04M	USD	Point-in-time
Balance	`StockholdersEquity`	$8.77M	USD	Point-in-time
Balance	`StockholdersEquity`	$6.17M	USD	Point-in-time
Balance	`StockholdersEquity`	$6.30M	USD	Point-in-time
Balance	`StockholdersEquity`	$1.35M	USD	Point-in-time
Balance	`StockholdersEquity`	$7.20M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.